Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Invitrogen

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Originally published in Science Express on 8 November 2007
Science 7 December 2007:
Vol. 318. no. 5856, pp. 1628 - 1632
DOI: 10.1126/science.1145918
Prev | Table of Contents | Next

Reports

DUBA: A Deubiquitinase That Regulates Type I Interferon Production

Nobuhiko Kayagaki,1 Qui Phung,2 Salina Chan,1 Ruchir Chaudhari,1 Casey Quan,1 Karen M. O'Rourke,1 Michael Eby,1 Eric Pietras,3 Genhong Cheng,3 J. Fernando Bazan,4 Zemin Zhang,5 David Arnott,2 Vishva M. Dixit1*

Production of type I interferon (IFN-I) is a critical host defense triggered by pattern-recognition receptors (PRRs) of the innate immune system. Deubiquitinating enzyme A (DUBA), an ovarian tumor domain-containing deubiquitinating enzyme, was discovered in a small interfering RNA–based screen as a regulator of IFN-I production. Reduction of DUBA augmented the PRR-induced IFN-I response, whereas ectopic expression of DUBA had the converse effect. DUBA bound tumor necrosis factor receptor–associated factor 3 (TRAF3), an adaptor protein essential for the IFN-I response. TRAF3 is an E3 ubiquitin ligase that preferentially assembled lysine-63–linked polyubiquitin chains. DUBA selectively cleaved the lysine-63–linked polyubiquitin chains on TRAF3, resulting in its dissociation from the downstream signaling complex containing TANK-binding kinase 1. A discrete ubiquitin interaction motif within DUBA was required for efficient deubiquitination of TRAF3 and optimal suppression of IFN-I. Our data identify DUBA as a negative regulator of innate immune responses.

1 Department of Physiological Chemistry, Genentech, South San Francisco, CA 94080, USA.
2 Department of Protein Chemistry, Genentech, South San Francisco, CA 94080, USA.
3 Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, CA 90095, USA.
4 Department of Protein Engineering, Genentech, South San Francisco, CA 94080, USA.
5 Department of Bioinformatics, Genentech, South San Francisco, CA 94080, USA.

* To whom correspondence should be addressed. E-mail: dixit{at}gene.com

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Regulation of I{kappa}B Kinase-related Kinases and Antiviral Responses by Tumor Suppressor CYLD.
M. Zhang, X. Wu, A. J. Lee, W. Jin, M. Chang, A. Wright, T. Imaizumi, and S.-C. Sun (2008)
J. Biol. Chem. 283, 18621-18626
   Abstract »    Full Text »    PDF »
Homo-oligomerization Is Essential for Toll/Interleukin-1 Receptor Domain-containing Adaptor Molecule-1-mediated NF-{kappa}B and Interferon Regulatory Factor-3 Activation.
K. Funami, M. Sasai, H. Oshiumi, T. Seya, and M. Matsumoto (2008)
J. Biol. Chem. 283, 18283-18291
   Abstract »    Full Text »    PDF »


ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)